Free Trial

Anika Therapeutics (ANIK) Competitors

Anika Therapeutics logo
$17.20 -0.25 (-1.43%)
Closing price 03/3/2025 04:00 PM Eastern
Extended Trading
$17.30 +0.10 (+0.58%)
As of 08:37 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ANIK vs. STAA, CERS, OSUR, UTMD, COO, WST, ALGN, MMSI, ICUI, and XRAY

Should you be buying Anika Therapeutics stock or one of its competitors? The main competitors of Anika Therapeutics include STAAR Surgical (STAA), Cerus (CERS), OraSure Technologies (OSUR), Utah Medical Products (UTMD), Cooper Companies (COO), West Pharmaceutical Services (WST), Align Technology (ALGN), Merit Medical Systems (MMSI), ICU Medical (ICUI), and DENTSPLY SIRONA (XRAY). These companies are all part of the "health care supplies" industry.

Anika Therapeutics vs.

STAAR Surgical (NASDAQ:STAA) and Anika Therapeutics (NASDAQ:ANIK) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, earnings, valuation, dividends, institutional ownership, media sentiment, profitability, risk and community ranking.

STAAR Surgical has a net margin of -6.44% compared to Anika Therapeutics' net margin of -59.40%. Anika Therapeutics' return on equity of -2.22% beat STAAR Surgical's return on equity.

Company Net Margins Return on Equity Return on Assets
STAAR Surgical-6.44% -3.35% -2.67%
Anika Therapeutics -59.40%-2.22%-1.75%

In the previous week, STAAR Surgical had 9 more articles in the media than Anika Therapeutics. MarketBeat recorded 12 mentions for STAAR Surgical and 3 mentions for Anika Therapeutics. Anika Therapeutics' average media sentiment score of 1.04 beat STAAR Surgical's score of 0.12 indicating that Anika Therapeutics is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
STAAR Surgical
2 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Anika Therapeutics
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

STAAR Surgical has a beta of 0.62, meaning that its share price is 38% less volatile than the S&P 500. Comparatively, Anika Therapeutics has a beta of 0.89, meaning that its share price is 11% less volatile than the S&P 500.

STAAR Surgical has higher revenue and earnings than Anika Therapeutics. STAAR Surgical is trading at a lower price-to-earnings ratio than Anika Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
STAAR Surgical$313.90M2.59-$20.21M-$0.41-40.17
Anika Therapeutics$164.17M1.53-$82.67M-$6.65-2.59

STAAR Surgical presently has a consensus price target of $26.86, indicating a potential upside of 63.07%. Anika Therapeutics has a consensus price target of $24.50, indicating a potential upside of 42.44%. Given STAAR Surgical's higher probable upside, research analysts plainly believe STAAR Surgical is more favorable than Anika Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
STAAR Surgical
1 Sell rating(s)
8 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Anika Therapeutics
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50

Anika Therapeutics received 14 more outperform votes than STAAR Surgical when rated by MarketBeat users. Likewise, 64.33% of users gave Anika Therapeutics an outperform vote while only 54.32% of users gave STAAR Surgical an outperform vote.

CompanyUnderperformOutperform
STAAR SurgicalOutperform Votes
289
54.32%
Underperform Votes
243
45.68%
Anika TherapeuticsOutperform Votes
303
64.33%
Underperform Votes
168
35.67%

96.7% of STAAR Surgical shares are owned by institutional investors. Comparatively, 91.5% of Anika Therapeutics shares are owned by institutional investors. 1.0% of STAAR Surgical shares are owned by company insiders. Comparatively, 7.9% of Anika Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

Anika Therapeutics beats STAAR Surgical on 9 of the 17 factors compared between the two stocks.

Get Anika Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ANIK and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ANIK vs. The Competition

MetricAnika TherapeuticsSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$251.91M$4.58B$5.81B$8.43B
Dividend YieldN/A36.92%4.76%3.97%
P/E Ratio-2.5930.3924.9119.24
Price / Sales1.5350.34375.92110.19
Price / Cash3.5351.0838.0534.58
Price / Book1.196.267.324.28
Net Income-$82.67M$67.64M$3.18B$247.04M
7 Day Performance-2.88%-5.18%-2.94%-3.26%
1 Month Performance-3.59%-9.68%-6.83%-6.57%
1 Year Performance-33.87%10.60%12.16%4.00%

Anika Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ANIK
Anika Therapeutics
4.074 of 5 stars
$17.20
-1.4%
$24.50
+42.4%
-31.6%$251.91M$164.17M-2.59300Positive News
Gap Up
STAA
STAAR Surgical
4.4338 of 5 stars
$16.22
-3.9%
$26.86
+65.6%
-50.6%$799.32M$313.90M-39.561,115Insider Trade
CERS
Cerus
2.2197 of 5 stars
$1.64
-0.6%
$3.63
+121.0%
-29.8%$304.56M$180.27M-14.91290
OSUR
OraSure Technologies
4.4437 of 5 stars
$3.99
+5.0%
$5.50
+37.8%
-50.9%$297.61M$405.47M26.60840Analyst Downgrade
Gap Up
UTMD
Utah Medical Products
3.0704 of 5 stars
$60.09
-0.2%
N/A-15.0%$203.71M$40.90M15.21180Positive News
COO
Cooper Companies
2.5898 of 5 stars
$90.06
+1.8%
$117.00
+29.9%
-10.3%$17.97B$3.90B46.1816,000Upcoming Earnings
Positive News
WST
West Pharmaceutical Services
4.9551 of 5 stars
$221.24
+4.9%
$344.00
+55.5%
-36.4%$16.00B$2.89B33.0710,600
ALGN
Align Technology
4.7488 of 5 stars
$190.72
+0.2%
$269.91
+41.5%
-41.6%$14.24B$4.00B34.0021,610Short Interest ↑
MMSI
Merit Medical Systems
3.5653 of 5 stars
$103.51
+0.3%
$109.80
+6.1%
+35.1%$6.03B$1.33B50.746,950Insider Trade
Analyst Revision
News Coverage
Positive News
ICUI
ICU Medical
4.5264 of 5 stars
$160.25
+1.9%
$199.67
+24.6%
+34.3%$3.92B$2.34B-35.0714,000Positive News
XRAY
DENTSPLY SIRONA
4.9081 of 5 stars
$19.05
+1.6%
$25.85
+35.7%
-51.9%$3.79B$3.90B-9.2015,000Dividend Announcement
Insider Trade
Analyst Revision
News Coverage

Related Companies and Tools


This page (NASDAQ:ANIK) was last updated on 3/4/2025 by MarketBeat.com Staff
From Our Partners